What TidalSense does
TidalSense makes N-Tidal Diagnose, a point-of-care device that measures respiratory physiology via a patented CO2 sensor and uses AI algorithms to deliver a COPD diagnosis with severity staging in as little as five minutes. The connected handset transmits breath data over 4G to a cloud platform used by clinicians, healthcare payers and pharmaceutical sponsors running Phase II/III respiratory trials. TidalSense, formerly Cambridge Respiratory Innovations, was founded in Cambridge in 2013 and has CE marking as a Class 2a medical device under EU MDR. The company has raised over $40m in total funding to date, including Innovate UK, SBRI and NIHR grants.
TidalSense is a healthcare tool on Falcoscan. Connected breath-test device that diagnoses COPD with AI in minutes. Falcoscan rates TidalSense with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. TidalSense is founded in 2013, currently at Series_b stage. Pricing: Paid.